Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation

Transplant Proc. 2003 Mar;35(2):820-1. doi: 10.1016/s0041-1345(03)00085-x.

Authors

M Castedal¹, A Siewert-Delle, M Olausson, S Friman

Affiliation

¹ Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.

PMID: 12644153
DOI: 10.1016/s0041-1345(03)00085-x

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antiviral Agents / therapeutic use*
Drug Therapy, Combination
Female
Follow-Up Studies
Hepacivirus / genetics
Hepacivirus / isolation & purification
Hepatitis C / drug therapy*
Hepatitis C / surgery*
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use*
Male
RNA, Viral / blood
RNA, Viral / genetics
Recombinant Proteins
Recurrence
Ribavirin / therapeutic use*
Treatment Outcome
Viremia / drug therapy

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
RNA, Viral
Recombinant Proteins
Ribavirin